Involvement of Monocarboxylate Transporter 4 Expression in Statin-Induced Cytotoxicity
Authors:
Open Access
- 1 April 2016
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (4) , 1544-1549
Abstract
No abstract availableKeywords
Funding Information
- YOKOYAMA Foundation for Clinical Pharmacology
This publication has 30 references indexed in Scilit:
- Crucial Residue Involved in L-Lactate Recognition by Human Monocarboxylate Transporter 4 (hMCT4)PLOS ONE, 2013
- Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubesFree Radical Biology and Medicine, 2012
- Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a ‘mitohormesis’ mechanism involving reactive oxygen species and PGC-1European Heart Journal, 2011
- AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscleLife Sciences, 2011
- Statin‐associated myopathy and its exacerbation with exerciseMuscle & Nerve, 2010
- Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of StatinsCirculation Research, 2010
- Association between risk of myopathy and cholesterol-lowering effect: A comparison of all statinsLife Sciences, 2008
- Toxicity of statins on rat skeletal muscle mitochondriaCellular and Molecular Life Sciences, 2006
- Elevated skeletal muscle phosphodiesters in adults using statin medicationsMuscle & Nerve, 2006
- Simvastatin induces impairment in skeletal muscle while heart is protectedBiochemical and Biophysical Research Communications, 2005